HCM
BIIB icon

Herndon Capital Management’s Biogen BIIB Stock Holding History

Herndon Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20
Closed -$6K – 256
2016
Q3 		$6K Hold
20
– – ﹤0.01% 221
2016
Q2 		$5K Sell
20
-1,617
-99% -$426K ﹤0.01% 257
2016
Q1 		$426K Hold
1,637
– – 0.01% 128
2015
Q4 		$501K Buy
+1,637
New +$470K 0.01% 128
2015
Q3 		– Sell
-5,084
Closed -$2.05M – 212
2015
Q2 		$2.05M Sell
5,084
-1,793
-26% -$720K 0.03% 77
2015
Q1 		$2.9M Buy
6,877
+742
+12% +$292K 0.04% 72
2014
Q4 		$2.08M Buy
6,135
+3,385
+123% +$1.1M 0.03% 84
2014
Q3 		$910K Buy
+2,750
New +$907K 0.01% 127

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Herndon Capital Management's BIIB Position: Q4 2016 in Review

Herndon Capital Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 20 shares — an estimated $6K sold.

Herndon Capital Management first reported a position in BIIB in Q3 2014 and held it in 8 quarters. The position peaked at $2.9M in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Herndon Capital Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Herndon Capital Management sold 20 Biogen shares in Q4 2016, an estimated $6K.
  • Herndon Capital Management first reported a position in Biogen in Q3 2014 and held it in 8 quarters.
  • Herndon Capital Management's Biogen position peaked at $2.9M in Q1 2015.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Herndon Capital Management's 13F filing for Q4 2016, filed 2 Feb 2017.